PARIS, July 26, 2024 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, today announced its collaboration with renowned geneticist, Professor Yannis Pitsiladis from Hong Kong Baptist University, on sports and anti-doping research. Utilizing MGI’s state-of-the-art DNBSEQ sequencers and automation platforms, the […]
Category Archives: Pr Newswire
HanAll reports strong financial performance with second quarter total revenue of 31.6 billion KRW, driven by the strong sales from the key products. HanAll expands collaboration with Turn Biotechnologies through an exclusive licensing agreement for Epigenetic Reprogramming of Aging (ERATM) technology, targeting ophthalmic and otic diseases. Progress in clinical development programs continued including the completion […]
BEIJING, July 26, 2024 /PRNewswire/ — On 25th July, China International Capital Corporation Limited (CICC) successfully held the 2024 CICC GBA Wealth Management Forum in Hong Kong. Themed “Developing New Quality Productive Forces, Driving New Momentum in Wealth”, the forum gathered a multitude of distinguished representatives from various sectors within the Guangdong-Hong Kong-Macao Greater Bay Area […]
SHENZHEN, China, July 26, 2024 /PRNewswire/ — Driven by production cuts and price increases from upstream manufacturers, alongside a gradual revival in the consumer electronics market, the memory industry is witnessing a recovery after two years of supply-demand imbalance and significant price declines, and behind it also hides a new trend in the industry fueled […]
JAKARTA, Indonesia, July 26, 2024 /PRNewswire/ — Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI) and its subsidiaries, BRI Group, reported a profit of IDR 29.90 trillion in the Second Quarter of 2024, achieved through selective and prudent growth. This was announced by BRI President Director, Sunarso, during the Q2 2024 financial performance press conference on […]
26
Jul
Jul
BOULDER, Colo., July 25, 2024 (GLOBE NEWSWIRE) — OnKure, Inc. today announced that Dylan Hartley, Ph.D. has been appointed to the position of Chief Scientific Officer. In this position, Dr. Hartley will lead the company’s research organization. “Dr. Hartley has a deep commitment to innovation and advancing drugs to improve patient care,” said Nicholas Saccomano, […]
26
Jul
Jul
Clinical benefit observed among non-small cell lung cancer (NSCLC) patients harboring mutant KRAS (mKRAS) variants in the Phase 2 mecbotamab vedotin (CAB-AXL-ADC) study; AXL tumoral expression highly associated with multiple mKRAS variants Evalstotug (CAB-CTLA-4 antibody) as a monotherapy and in combination with PD-1 continues to provide promising anti-tumor activity with a differentiated safety profile associated […]
26
Jul
Jul
SOUTH SAN FRANCISCO, Calif., July 25, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the human genome, announced today that it will report financial results for the first quarter of fiscal year 2025 (FY2025) after […]
26
Jul
Jul
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced it will report second quarter 2024 financial results on Thursday, August 1, 2024, after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business […]
Pr Newswire
FDA Grants Orphan Drug and Rare Pediatric Disease Designation Status to Cellectis’ UCART22 product candidate for Acute Lymphoblastic Leukemia (ALL) Treatment
26
Jul
Jul
ALL represents 10% of all leukemia cases in the United States, progresses rapidly, and is typically fatal within weeks or months if left untreated1 There is an urgent need to develop new therapies for ALL for patients who are not candidates for hematopoietic stem cell transplantation (HSCT) or relapse after FDA ODD and RPDD designations […]